Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase 1 3Phase 4 2Phase 1/2 2Phase NA 1

Status

Completed 13Terminated 6Unknown 3Withdrawn 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Thoracic 1

Conditions

Leukemia, Myeloid, Acute 2Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 51fludarabine 38Injections 32Gemcitabine 25Paclitaxel 24Cisplatin 22Radiotherapy 19toripalimab 18pembrolizumab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 14Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Immunotherapy, Adoptive 11Cetuximab 11Bevacizumab 10Irinotecan 9Drug Therapy 9sintilimab 8Etoposide 8aldesleukin 7Taxes 7Rituximab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Arsenic Trioxide × Clear all
NCT03855371 2022-11-04

PANDA-T0

Ruijin Hospital

Phase 1 Unknown
5 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05297123 2022-03-28

Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid Acid

First Affiliated Hospital Xi'an Jiaotong University

Phase 1 Unknown
30 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02066870 2015-03-13

Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI

Betta Pharmaceuticals Co., Ltd.

Phase 1 Unknown
9 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡